Effect of diet on plasma total antioxidant status in phenylketonuric patients

European Journal of Clinical Nutrition

Volumn 57, Issue 2, 2003, Pages 383-387

  Schulpis, K H ^a   Tsakiris, S ^b   Karikas, G A ^a   Moukas, M ^b   Behrakis, P ^b  

^a AGHIA SOPHIA CHILDREN S HOSPITAL   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

tocopherol; carotene; Antioxidant status; Phenylketonuria; Vegetarian diet; Vitamin C

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; LIPID; PHENYLALANINE;

ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; DIET THERAPY; DIETARY INTAKE; FEMALE; HUMAN; LIPID BLOOD LEVEL; MALE; NUTRIENT; PATIENT COMPLIANCE; PHENYLKETONURIA; STATISTICAL SIGNIFICANCE; VEGETARIAN DIET; VITAMIN BLOOD LEVEL; VITAMIN INTAKE;

ANALYSIS OF VARIANCE; ANTIOXIDANTS; CHILD; DIET, VEGETARIAN; FEMALE; HUMANS; MALE; PHENYLKETONURIAS;

EID: 0037327453     PISSN: 09543007     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ejcn.1601529     Document Type: Article

References (28)

1. Dwyer TT (1988): Health aspects of vegetarian diet. Am. J. Clin. Nutr. 48, 712-738.
2. Faggiano A, Pivonello R, Melis D, Alfieri R, Filippela M, Spagnuolo G, Salvatore F, Lombardi G & Colao A (2002): Evaluation of circulating levels and renal clearence of natural amino acids in patients with Cushing disease. J. Endocrinol. Invest. 25, 142-151.
3. Frolich L & Riederer P (1995): Free radical mechanisms of Alzheimer Type and the potential for antioxidative treatment. Arzeim. Forsch. Drug Res. 45, 443-446.
4. Halliwell B & Gutteridge JMC (1989): Free radicals in Biology and Medicine, 2nd edn, pp 110-119. Oxford: Clarendon Press.
5. Hess D, Keller HE, Oberlin B, Bonfanti R & Schuep W (1991): Simultaneous determination of retinol, tocopherols, carotenes and lycopene in plasma by means of HPLC on reversed phase. Int. J. Vitam. Nutr. Res. 61, 232-238.
6. Hurnham DL, Davies JA & Crump BJ (1986): The use of different lipids to express vitamin E status. Ann. Clin. Biochem. 23, 514-520.
7. Jialal J, Norkus EP & Cristol J (1991): β-Carotene inhibits the oxidative modification of LDL. Biochim. Biophys. Acta 1086, 134-138.
8. Jushi L, Folsom A, Prineas R, Mink P & Bostick R (1996): Dietary antioxidant vitamins and death from coronary heart disease in postmenopausal women. New Engl. J. Med. 334, 1156-1162.
9. Klipstein-Grobusch K, Geleijnse J, Den Breeijen J, Boeing H, Hofman A, Grober D & Witteman J (1999): Dietary antioxidants and risk of myocardial infarction in the elderly: the Rotterdam Study. Am. J. Clin. Nutr. 69, 261-266.
10. Knekt P, Reunanen A & Sappanen R (1994): Antioxidant vitamin intake and coronary mortality in a longitudinal population study. Am. J. Epidemiol. 139, 1180-1189.
11. Miller NJ, Rice-Evans C, Davies MJ, Copinathan V & Milner A (1993): A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates. Clin. Soc. (Colch.) 84, 407-412.
12. Pan Wen Ham, Chia Jung Chin & Chin Tou Shew (1993): Haemostatic factors and blood lipids in Buddishist vegetarian and omnivores. Am. J. Clin. Nutr. 58, 334-359.
13. Parks EJ, German JB & Davis PA (1998): Reduced oxidative susceptibility of LDL from patients participating in an intensive atherosclerosis treatment program. Am. J. Clin. Nutr. 63, 778-785.
14. Paul AA, Southgate DA & Russel J (1980): The Composition of the Food. London: HMSO.
15. Pietinen R, Rimm E, Korhonen P, Hartman A & Willet W (1996): Intake of Dietary fiber and risk of coronary heart disease in a Cohort of Finnish Men. Circulation 94, 2720-2727.
16. Reaven PD & Witzturn JL (1996): Oxidised low density lipoproteins in atherogenesis. A. Rev. Nut. 16, 51-71.
17. Sacks F (1994): Dietary fats and coronary heart disease. J. Cardiovasc. Risk 1, 3-8.
18. Sato K, Niki E & Shimasaki H (1990): Free radical mediated chain oxidation of LDL and its synergistic inhibition by vitamin E and vitamin C. Arch. Biochem. Biophy. 279, 402-405.
19. Schulpis KH & Scarpalezou A (1988): Triglycerides, cholesterol. HDL, LDL and VLDL cholesterol in serum pf phenylketonuric patients. Clin. Pediatr. 28, 466-469.
20. Scriver C, Kaufman S, Eisensmith R & Woo S (2000): The Hyperphenylalaninemias In: The Metabolic and Molecular Bases of Inherited Disease, 8th edn, ed. S Scriver, A Beaudet, W Sly & D Valle, pp 1667-1724. Newyork: McGraw-Hill.
21. Strube M, Haenen GR, Van den Berg H & Bast A (1997): Pitfalls in a method for assessment of total antioxidant capacity. Free Radic. Res. 26, 515-521.
22. Sun JZ, Kaur H, Hadliwell B & Li Xz (1993): Use of aromatic phenylalanine to measure production of hydroxyl radicals after myocardial ischemia in vivo. Circul. Res. 73, 534-549.
23. Vahouny GV (1982): Dietary fiber, lipid metabolism and atherosclerosis. Fed. Proc 41, 2801-2806.
24. Van Bakel MM, Printezen G, Wermuth B & Weismann UM (2000): Antioxidant and thyroid hormone status in selenium deficient phenylketonuric and hyperphenylalaninemic patients. Am. J. Clin. Nutr. 12, 976-981.
25. Van der Vliet A, O'Neil CA, Halliwell B, Cross CE & Kaur H (1994): Aromatic hydroxylation and nitration of phenylalanine and tyrosine by peroxynitrite. FEBS Lett. 339, 89-92.
26. Vuilleumier JP & Keek E (1991): Fluorometric assay of vitamin C. J. Micronutr. Anal. 5, 25-34.
27. Wendel U, Koppelkamm M, Hummel W & Sauder J (1990): A new approach to the newborn screening for hyperphenylalaninemias use L-phenylalanine dehydrogenase and microtiter plates. Clin. Chim. Acta 192, 165-170.
28. Weststrate JA & Van het Hof KH (1995): Sucrose polyester and plasma carotenoid concentration in healthy subjects. Am. J. Clin. Nutr. 62, 591-597.